4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
6.67
+0.52 (8.46%)
At close: Aug 13, 2025, 4:00 PM
6.42
-0.25 (-3.75%)
Pre-market: Aug 14, 2025, 9:16 AM EDT
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 227 employees as of December 31, 2024. The number of employees increased by 80 or 54.42% compared to the previous year.
Employees
227
Change (1Y)
80
Growth (1Y)
54.42%
Revenue / Employee
$145
Profits / Employee
-$864,070
Market Cap
311.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 227 | 80 | 54.42% |
| Dec 31, 2023 | 147 | 7 | 5.00% |
| Dec 31, 2022 | 140 | 16 | 12.90% |
| Dec 31, 2021 | 124 | 41 | 49.40% |
| Dec 31, 2020 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FDMT News
- 3 days ago - 4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones - GlobeNewsWire
- 8 days ago - 4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 12 days ago - 4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study - Benzinga
- 13 days ago - 4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update - GlobeNewsWire
- 21 days ago - 4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists - GlobeNewsWire
- 4 weeks ago - 4DMT Announces New Employment Inducement Grants - GlobeNewsWire
- 6 weeks ago - 4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution - GlobeNewsWire
- 2 months ago - 4DMT to Participate in Upcoming Investor Conferences - GlobeNewsWire